Milestone Group »

Aurinia Pharmaceuticals shares owned by Milestone Group

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Milestone Group from 13F filings

Historical chart of Milestone Group investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by Milestone Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by Milestone Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $32k 2.0k 15.95

More positions owned by Milestone Group

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Gold Tr Shares Represent (IAUM)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Ishares Tr S&p 500 Val Etf (IVE)

View all positions for Milestone Group

Top funds holding Aurinia Pharmaceuticals

Tang Capital Management
BlackRock
NEA Management Company
Arrowstreet Capital, Limited Partnership
State Street Corporation
Renaissance Technologies
Marshall Wace
Geode Capital Management
Jane Street
Vanguard Group
Two Sigma Investments
Nomura Holdings
Jacobs Levy Equity Management
Henderson Group
Goldman Sachs Group

View all funds holding Aurinia Pharmaceuticals